Results 201 to 210 of about 176,259 (332)

Intraductal papillary mucinous neoplasm of the pancreas with a bifid pancreatic duct [PDF]

, 2009
Yoshitsugu Tajima, Tomohiko Adachi, Tamotsu Kuroki, Noritsugu Tsuneoka, Takehiro Mishima, Taiichiro Kosaka, Takashi Kanematsu   +6 more
openalex   +1 more source

Iron‐MOFs for Biomedical Applications

Advanced Healthcare Materials, Volume 14, Issue 8, March 25, 2025.
This review introduces the unique properties of iron‐based metal–organic frameworks (Fe‐MOFs), the advances in synthesis and formulation, and their state‐of‐the‐art applications in biomedicine. It discusses the challenges in transitioning Fe‐MOFs from research to clinical use, emphasizing the need for eco‐friendly production methods, and a deeper ...
Zhihao Yu, Mathilde Lepoitevin, Christian Serre   +2 more
wiley   +1 more source

Rapidly growing poorly differentiated adenocarcinoma of pancreatic remnant after resection of intraductal papillary-mucinous neoplasm (IPMN)

, 2005
Kenji Yamao, Yasuhiro Shimizu, Nobumasa Mizuno, Kuniyuki Takahashi, Akira Sawaki, Akio Yanagisawa   +5 more
openalex   +2 more sources

Pancreatic cystic neoplasms: why not operate? [PDF]

, 2009
Jeffrey A. Drebin
openalex   +1 more source

Leveraging Organ‐on‐Chip Models to Investigate Host–Microbiota Dynamics and Targeted Therapies for Inflammatory Bowel Disease

Advanced Healthcare Materials, Volume 14, Issue 10, April 15, 2025.
The challenges of studying inflammatory bowel disease (IBD), highlighting limitations of traditional 2D cell cultures and animal models are discussed here. It introduces human intestine organ‐on‐chip (OoC) models as a promising alternative, capable of more accurately mimicking the intestinal microenvironment.
Tim Kaden, Raquel Alonso‐Román, Johannes Stallhofer, Mark S. Gresnigt, Bernhard Hube, Alexander S. Mosig   +5 more
wiley   +1 more source

Variation in Hospital Utilization of Minimally Invasive Distal Pancreatectomy for Localized Pancreatic Neoplasms. [PDF]

J Gastrointest Surg, 2020
Ellis RJ, Zhang LM, Ko CY, Cohen ME, Bentrem DJ, Bilimoria KY, Yang AD, Talamonti MS, Merkow RP.   +8 more
europepmc   +1 more source

IDENTIFICATION OF UNIQUE DIFFERENTIAL PROTEOMIC BIOMARKERS IN PANCREATIC CYSTIC NEOPLASM FLUID

, 2006
James J. Farrell, Puneet Souda, Babak Hasanzadeh, Julian P. Whitelegge, Kym F. Faull   +4 more
openalex   +1 more source

Adjuvant Chemoradiotherapy After Pancreatic Resection for Invasive Carcinoma Associated With Intraductal Papillary Mucinous Neoplasm of the Pancreas [PDF]

, 2009
Michael J. Swartz, Charles C. Hsu, Timothy M. Pawlik, Jordan M. Winter, Ralph H. Hruban, Mehmet Güler, Richard D. Schulick, John L. Cameron, Daniel A. Laheru, Christopher L. Wolfgang, Joseph M. Herman   +10 more
openalex   +1 more source

Precision Photothermal Therapy at Mild Temperature: NIR‐II Imaging‐Guided, H2O2‐Responsive Stealth Nanobomb

Advanced Healthcare Materials, EarlyView.
The new generation nanobomb, termed the stealth nanobomb, is fabricated through self‐assembly using a polymeric carbon monoxide carrier (PLGA(CO)), small molecule near‐infrared‐active agents (2TT‐OC46B), and phospholipid polyethylene glycol (DSPE‐mPEG2000). The stealth nanobomb can circulate in the bloodstream and specifically target pancreatic cancer,
Gongcheng Ma, Qihang Ding, Yue Wang, Zhiwei Zhang, Yuding Zhang, Hui Shi, Lintao Cai, Ping Gong, Pengfei Zhang, Zhen Cheng, Jong Seung Kim   +10 more
wiley   +1 more source

Subtype-associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms. [PDF]

J Pathol Clin Res
Németh K, Mezei E, Vörös J, Borka K, Pesti A, Kenessey I, Kiss A, Budai A.   +7 more
europepmc   +1 more source